GTS Securities’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-34,440
| Closed | -$2.42M | – | 1350 |
|
|
2024
Q3 | $2.42M | Buy |
34,440
+12,221
| +55% | +$859K | 0.01% | 354 |
|
|
2024
Q2 | $1.83M | Buy |
22,219
+8,987
| +68% | +$740K | ﹤0.01% | 428 |
|
|
2024
Q1 | $1.16M | Sell |
13,232
-13,661
| -51% | -$1.19M | ﹤0.01% | 499 |
|
|
2023
Q4 | $2.59M | Buy |
26,893
+15,039
| +127% | +$1.45M | ﹤0.01% | 331 |
|
|
2023
Q3 | $1.05M | Buy |
11,854
+6,759
| +133% | +$598K | ﹤0.01% | 499 |
|
|
2023
Q2 | $442K | Buy |
+5,095
| New | +$442K | 0.01% | 711 |
|